{"tid":2105357,"cid":15,"subCid":0,"title":"[9939.HK]自願公告 普克魯胺治療COVID-19研究的臨床試驗合作","createTime":"2020-07-12T14:51:02.000Z","updateTime":"2020-07-12T15:04:12.000Z","uid":59309,"like":2,"dislike":1,"uniUserReply":3,"replies":[{"pid":"06e6aadee80a578265983b19083fa0e2931f38d3","tid":2105357,"uid":59309,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-07-12T14:51:02.000Z","msg":"本公告由開拓藥業有限公司*（「本公司」，連同其附屬公司統稱「本集團」）自願刊<br />\n發。<br />\n於2020年7月7日，蘇州開拓藥業股份有限公司（「蘇州開拓」）（本公司全資附屬公<br />\n司）與Applied Biology, Inc.（「Applied Biology」）訂立臨床試驗研究協議（「研究協<br />\n議」），據此，蘇州開拓聘請Applied Biology進行普克魯胺(GT0918)治療新型冠狀<br />\n病毒肺炎（「COVID-19」）的研究。<br />\n<br />\n<a href=\"https://www1.hkexnews.hk/listedco/listconews/sehk/2020/0712/2020071200056_c.pdf\" data-sr-url=\"https://r.lihkg.com/link?u=https%3A%2F%2Fwww1.hkexnews.hk%2Flistedco%2Flistconews%2Fsehk%2F2020%2F0712%2F2020071200056_c.pdf&d=Z5C23SoLFrdwUrTWaDZos%2BrkGmmZttFFipzpmUasbQ8%3D&h=bd7c95c6\" data-auto-link target=\"_blank\">https://www1.hkexnews.hk/listedco/listconews/sehk/2020/0712/2020071200056_c.pdf</a>"},{"pid":"6032d2c6ae57adc36d106718f3e63c093c673164","tid":2105357,"uid":13420,"like":1,"dislike":0,"score":1,"citedBy":0,"replyTime":"2020-07-12T15:00:30.000Z","msg":"想食饅頭喎<img src=\"/assets/faces/mouse/please.gif\" class=\"hkgmoji\" />"},{"pid":"0e457929aec5f91e0a8cc1060d6e5826303e25ff","tid":2105357,"uid":239510,"like":1,"dislike":0,"score":1,"citedBy":0,"replyTime":"2020-07-12T15:04:12.000Z","msg":"垃圾股 整個咁既協議 班傻散又狗衝入去 <br />\n千升<img src=\"/assets/faces/lm2/support.gif\" class=\"hkgmoji\" />"}]}